Israeli medical company Endobetix, which developed an implant to treat for type 2 diabetes, has raised $2.5 million. Endobetix is developing a nonsurgical implant that mimics the hormonal benefits offered by bariatric surgery, usually given to diabetic, obese people. The company’s product, which costs $5,000, may replace the irreversible, $30,000 surgical procedure. The company is part of the Misgav Venture Accelerator, which serves Israeli medical startups.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

AI Startup Helps Doctors Analyze Heart Scans
February 08, 2023

AI Monitors High-Speed Conveyor Belts For Defects
February 08, 2023

Israel Hi-Tech Group In Rescue Mission To Turkey
February 08, 2023

Israeli Startup Tests Cancer Treatment With Pharma Giant
February 07, 2023
Facebook comments